vs
American Outdoor Brands, Inc.（AOUT）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
American Outdoor Brands, Inc.的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.6倍（$57.2M vs $35.5M），American Outdoor Brands, Inc.净利率更高（3.6% vs -304.2%，领先307.9%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -5.0%），American Outdoor Brands, Inc.自由现金流更多（$-14.1M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 3.5%）
Deckers Brands（原Deckers Outdoor Corporation）是美国鞋履设计与分销企业，1973年成立，总部位于加利福尼亚州戈利塔，由道格·奥托与卡尔·F·洛普克创立，旗下拥有UGG、Teva、Hoka等多个知名品牌。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
AOUT vs RXRX — 直观对比
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $57.2M | $35.5M |
| 净利润 | $2.1M | $-108.1M |
| 毛利率 | 45.6% | 59.8% |
| 营业利润率 | 3.7% | -304.8% |
| 净利率 | 3.6% | -304.2% |
| 营收同比 | -5.0% | 681.7% |
| 净利润同比 | -33.3% | 39.6% |
| 每股收益（稀释后） | $0.16 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $57.2M | $35.5M | ||
| Q3 25 | $29.7M | $5.2M | ||
| Q2 25 | $61.9M | $19.2M | ||
| Q1 25 | $58.5M | $14.7M | ||
| Q4 24 | $60.2M | $4.5M | ||
| Q3 24 | $41.6M | $26.1M | ||
| Q2 24 | $46.3M | $14.4M | ||
| Q1 24 | $53.4M | $13.8M |
| Q4 25 | $2.1M | $-108.1M | ||
| Q3 25 | $-6.8M | $-162.3M | ||
| Q2 25 | $-992.0K | $-171.9M | ||
| Q1 25 | $169.0K | $-202.5M | ||
| Q4 24 | $3.1M | $-178.9M | ||
| Q3 24 | $-2.4M | $-95.8M | ||
| Q2 24 | $-5.3M | $-97.5M | ||
| Q1 24 | $-2.9M | $-91.4M |
| Q4 25 | 45.6% | 59.8% | ||
| Q3 25 | 46.7% | -183.8% | ||
| Q2 25 | 40.9% | -4.9% | ||
| Q1 25 | 44.7% | -48.0% | ||
| Q4 24 | 48.0% | -181.4% | ||
| Q3 24 | 45.4% | 53.7% | ||
| Q2 24 | 41.9% | 36.2% | ||
| Q1 24 | 42.7% | 19.1% |
| Q4 25 | 3.7% | -304.8% | ||
| Q3 25 | -23.0% | -3327.6% | ||
| Q2 25 | -1.5% | -916.8% | ||
| Q1 25 | 0.5% | -1297.9% | ||
| Q4 24 | 5.1% | -4042.4% | ||
| Q3 24 | -6.2% | -377.1% | ||
| Q2 24 | -11.9% | -697.4% | ||
| Q1 24 | -5.4% | -698.4% |
| Q4 25 | 3.6% | -304.2% | ||
| Q3 25 | -23.0% | -3135.3% | ||
| Q2 25 | -1.6% | -894.2% | ||
| Q1 25 | 0.3% | -1373.3% | ||
| Q4 24 | 5.2% | -3935.5% | ||
| Q3 24 | -5.7% | -367.5% | ||
| Q2 24 | -11.5% | -676.6% | ||
| Q1 24 | -5.4% | -662.4% |
| Q4 25 | $0.16 | $-0.17 | ||
| Q3 25 | $-0.54 | $-0.36 | ||
| Q2 25 | $-0.08 | $-0.41 | ||
| Q1 25 | $0.01 | $-0.50 | ||
| Q4 24 | $0.24 | $-0.56 | ||
| Q3 24 | $-0.18 | $-0.34 | ||
| Q2 24 | $-0.41 | $-0.40 | ||
| Q1 24 | $-0.23 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.1M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $170.4M | $1.1B |
| 总资产 | $240.9M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $3.1M | $743.3M | ||
| Q3 25 | $17.8M | $659.8M | ||
| Q2 25 | $23.4M | $525.1M | ||
| Q1 25 | $17.1M | $500.5M | ||
| Q4 24 | $14.2M | $594.4M | ||
| Q3 24 | $23.5M | $427.6M | ||
| Q2 24 | $29.7M | $474.3M | ||
| Q1 24 | $15.9M | $296.3M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
| Q4 25 | $170.4M | $1.1B | ||
| Q3 25 | $167.8M | $1.0B | ||
| Q2 25 | $177.6M | $919.1M | ||
| Q1 25 | $178.7M | $933.9M | ||
| Q4 24 | $178.9M | $1.0B | ||
| Q3 24 | $175.7M | $524.6M | ||
| Q2 24 | $177.9M | $584.4M | ||
| Q1 24 | $182.4M | $401.2M |
| Q4 25 | $240.9M | $1.5B | ||
| Q3 25 | $241.9M | $1.4B | ||
| Q2 25 | $246.4M | $1.3B | ||
| Q1 25 | $245.9M | $1.3B | ||
| Q4 24 | $254.1M | $1.4B | ||
| Q3 24 | $244.8M | $726.5M | ||
| Q2 24 | $240.6M | $775.9M | ||
| Q1 24 | $239.1M | $557.8M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-13.3M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-14.1M | $-47.3M |
| 自由现金流率自由现金流/营收 | -24.6% | -133.1% |
| 资本支出强度资本支出/营收 | 1.3% | 3.5% |
| 现金转化率经营现金流/净利润 | -6.41× | — |
| 过去12个月自由现金流最近4个季度 | $-4.7M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $-13.3M | $-46.1M | ||
| Q3 25 | $-1.7M | $-117.4M | ||
| Q2 25 | $7.8M | $-76.4M | ||
| Q1 25 | $5.9M | $-132.0M | ||
| Q4 24 | $-7.9M | $-115.4M | ||
| Q3 24 | $-4.4M | $-59.2M | ||
| Q2 24 | $14.7M | $-82.2M | ||
| Q1 24 | $13.0M | $-102.3M |
| Q4 25 | $-14.1M | $-47.3M | ||
| Q3 25 | $-2.0M | $-117.6M | ||
| Q2 25 | $7.2M | $-79.6M | ||
| Q1 25 | $4.2M | $-133.8M | ||
| Q4 24 | $-8.0M | $-116.7M | ||
| Q3 24 | $-5.2M | $-63.8M | ||
| Q2 24 | $14.2M | $-83.4M | ||
| Q1 24 | $9.7M | $-109.0M |
| Q4 25 | -24.6% | -133.1% | ||
| Q3 25 | -6.7% | -2272.5% | ||
| Q2 25 | 11.6% | -413.9% | ||
| Q1 25 | 7.2% | -907.4% | ||
| Q4 24 | -13.3% | -2567.7% | ||
| Q3 24 | -12.5% | -244.6% | ||
| Q2 24 | 30.6% | -578.5% | ||
| Q1 24 | 18.2% | -789.9% |
| Q4 25 | 1.3% | 3.5% | ||
| Q3 25 | 1.0% | 4.7% | ||
| Q2 25 | 0.9% | 16.4% | ||
| Q1 25 | 2.9% | 12.4% | ||
| Q4 24 | 0.1% | 28.6% | ||
| Q3 24 | 2.0% | 17.5% | ||
| Q2 24 | 1.1% | 8.2% | ||
| Q1 24 | 6.2% | 48.2% |
| Q4 25 | -6.41× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 34.86× | — | ||
| Q4 24 | -2.55× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AOUT
| Traditional Channels Net Sales | $36.8M | 64% |
| E Commerce Channels Net Sales | $20.4M | 36% |
RXRX
暂无分部数据
